Thymus gland and myasthenia gravis study
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study looks at how the thymus gland and certain antibodies relate to myasthenia gravis, a condition that causes muscle weakness. It may help doctors understand the disease better and could lead to improved treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can provide a blood sample to test for myasthenia gravis antibodies.
- You have had a chest CT or MRI scan.
- You have either a thymus gland tumor (thymoma), other thymus gland changes, or a myasthenia gravis diagnosis.
- You are not pregnant or breastfeeding, and you do not have other muscle or nerve diseases that could confuse the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for myasthenia gravis (a nerve-muscle condition causing weakness) that occurs with a thymoma (a tumor in the thymus). You will receive one of two medicines before surgery to remove the thymoma, to see which better improves muscle strength and daily function.
This study looks at how often myasthenia gravis symptoms return within six months after having the thymus gland removed (thymectomy), and what factors might predict that early return. The goal is to help doctors understand the disease better and improve future treatment planning.
This 10-year study collects information from people with myasthenia gravis to learn more about the condition and improve care. By sharing your experiences, you can help researchers understand what daily life is like and shape future treatments.
This trial is a global registry for people with myasthenia gravis (MG). It collects information to help researchers better understand MG and improve care.
This study looks at bladder and sexual problems that people with generalized myasthenia gravis may have. It uses questionnaires to learn more about these issues and how they affect daily life.
This study uses lab-grown mini muscle-nerve cells (organoids) to better understand severe, hard-to-treat myasthenia gravis. It may help researchers find new treatment options for people with the AChR antibody type.
Hear when a new Myasthenia Gravis Associated With Thymoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.